Medical cannabis: doctors left to handle “backlash” from patients over lack of availability, MPs sayBMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4502 (Published 02 July 2019) Cite this as: BMJ 2019;366:l4502
- Gareth Iacobucci
- The BMJ
The UK government and the drug industry should act urgently to tackle “major gaps” in the evidence base for use of medical cannabis that are restricting availability despite a rescheduling of the drugs last year, a parliamentary inquiry has concluded.
In a report published on Wednesday 3 July the House of Commons Health and Social Care Committee noted that although specialist doctors have been able to prescribe cannabis since November 2018, very few prescriptions have been issued, as most forms of medical cannabis are unlicensed and have not been approved by the National Institute for Health and Care Excellence.1
Poor communication from the …